4/A//SEC Filing
Mosseri Marlio Charles 4/A
Accession 0001104659-25-047089
CIK 0001875558other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 9:25 AM ET
Size
13.9 KB
Accession
0001104659-25-047089
Insider Transaction Report
Form 4/AAmended
Mosseri Marlio Charles
10% Owner
Transactions
- Purchase
Common Stock
2025-05-09$8.90/sh+9,817$87,412→ 2,931,199 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-08$8.71/sh+100$871→ 2,909,132 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-09$8.95/sh+9,850$88,128→ 2,921,382 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-08$8.99/sh+100$899→ 2,909,032 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-09$8.98/sh+5,395$48,426→ 2,936,594 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-08$8.97/sh+2,400$21,528→ 2,911,532 total(indirect: By Emerald Hill Ventures SARL SPF.)
Footnotes (3)
- [F1]Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.
- [F2]The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to correct the price of securities acquired by the reporting in the reported transactions.
- [F3]The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to include transactions that occurred on May 9, 2025.
Documents
Issuer
Nuvectis Pharma, Inc.
CIK 0001875558
Entity typeother
Related Parties
1- filerCIK 0001806384
Filing Metadata
- Form type
- 4/A
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 9:25 AM ET
- Size
- 13.9 KB